BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (WKN:500625), developing the first-of-its-kind artificial liver device, is pleased to announce the addition of Prof. Jörg C. Gerlach, MD, PhD, to the Company’s Scientific Advisory Board.
